ACUTE MYOCARDIAL INFARCTION OF ANTERIOR WALL

Clinical trials for ACUTE MYOCARDIAL INFARCTION OF ANTERIOR WALL explained in plain language.

Never miss a new study

Get alerted when new ACUTE MYOCARDIAL INFARCTION OF ANTERIOR WALL trials appear

Sign up with your email to follow new studies for ACUTE MYOCARDIAL INFARCTION OF ANTERIOR WALL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New drug aims to shrink heart attack scar in major trial

Disease control Not yet recruiting

This study tests whether an investigational drug called NL005 can reduce permanent heart muscle damage in people who have had a severe heart attack (STEMI) and undergone emergency artery-opening treatment. About 189 participants will receive either a low dose, high dose, or place…

Matched conditions: ACUTE MYOCARDIAL INFARCTION OF ANTERIOR WALL

Phase: PHASE2 • Sponsor: Beijing Northland Biotech. Co., Ltd. • Aim: Disease control

Last updated May 26, 2026 12:10 UTC

ACUTE MYOCARDIAL INFARCTION OF ANTERIOR WALL

Get alerted when new ACUTE MYOCARDIAL INFARCTION OF ANTERIOR WALL trials appear

New drug aims to shrink heart attack scar in major trial